Skip to content
10-Q

Quarterly Report

AVITA MEDICAL, INC. AVHHL RCEL

0001193125-25-269597

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 30.49M sh
Shares Diluted Q3 2025 · Sep 30, 2025 28.39M sh
Shares Diluted Q3 2025 · Sep 30, 2025 27.01M sh
Shares Diluted Q3 2025 · Sep 30, 2024 25.98M sh
Shares Diluted Q3 2025 · Sep 30, 2024 25.79M sh
Capex Q3 2025 · Sep 30, 2025 $1.68M
Capex Q3 2025 · Sep 30, 2024 $7.56M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$25.76M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$40.86M
Long Term Debt Q3 2025 · Sep 30, 2025 $0
Long Term Debt Q3 2025 · Dec 31, 2024 $42.25M
Short Term Debt Q3 2025 · Sep 30, 2025 $42.45M
Short Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $15.42M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $14.05M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$6.67M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$12.89M
Stockholders Equity Q3 2025 · Dec 31, 2024 $4.5M
Stockholders Equity Q3 2025 · Sep 30, 2024 $12.23M
Stockholders Equity Q3 2025 · Jun 30, 2024 $23.92M
Stockholders Equity Q3 2025 · Dec 31, 2023 $49.06M
Current Liabilities Q3 2025 · Sep 30, 2025 $61.83M
Current Liabilities Q3 2025 · Dec 31, 2024 $20.16M
Total Liabilities Q3 2025 · Sep 30, 2025 $70.39M
Total Liabilities Q3 2025 · Dec 31, 2024 $74.97M
Current Assets Q3 2025 · Sep 30, 2025 $41.37M
Current Assets Q3 2025 · Dec 31, 2024 $57M
Total Assets Q3 2025 · Sep 30, 2025 $63.73M
Total Assets Q3 2025 · Dec 31, 2024 $79.71M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.46
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.37
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.62
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.95
Eps Basic Q3 2025 · Sep 30, 2025 −$0.46
Eps Basic Q3 2025 · Sep 30, 2025 −$1.37
Eps Basic Q3 2025 · Sep 30, 2024 −$0.62
Eps Basic Q3 2025 · Sep 30, 2024 −$1.95
Sga Expense Q3 2025 · Sep 30, 2025 $7.23M
Sga Expense Q3 2025 · Sep 30, 2025 $20.28M
Sga Expense Q3 2025 · Sep 30, 2024 $9.59M
Sga Expense Q3 2025 · Sep 30, 2024 $26.07M
Rd Expense Q3 2025 · Sep 30, 2025 $3.75M
Rd Expense Q3 2025 · Sep 30, 2025 $15.15M
Rd Expense Q3 2025 · Sep 30, 2024 $5.43M
Rd Expense Q3 2025 · Sep 30, 2024 $15.51M
Net Income Q3 2025 · Sep 30, 2025 −$13.19M
Net Income Q3 2025 · Sep 30, 2025 −$36.97M
Net Income Q3 2025 · Sep 30, 2024 −$16.21M
Net Income Q3 2025 · Sep 30, 2024 −$50.26M
Operating Income Q3 2025 · Sep 30, 2025 −$9.15M
Operating Income Q3 2025 · Sep 30, 2025 −$32.13M
Operating Income Q3 2025 · Sep 30, 2024 −$13.81M
Operating Income Q3 2025 · Sep 30, 2024 −$46.64M
Gross Profit Q3 2025 · Sep 30, 2025 $13.88M
Gross Profit Q3 2025 · Sep 30, 2025 $44.51M
Gross Profit Q3 2025 · Sep 30, 2024 $16.36M
Gross Profit Q3 2025 · Sep 30, 2024 $39.03M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $3.19M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $9.49M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $3.19M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $6.81M
Revenue Q3 2025 · Sep 30, 2025 $17.06M
Revenue Q3 2025 · Sep 30, 2025 $54M
Revenue Q3 2025 · Sep 30, 2024 $19.55M
Revenue Q3 2025 · Sep 30, 2024 $45.85M